Recent advances. Diagnosis and treatment of early breast cancer

British Medical Journal

Volumn 314, Issue 7096, 1997, Pages 1736-1739

  Silverstein, Melvin J ^a  

^a The Breast Center Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURGERY; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE DISSECTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031006204     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7096.1736     Document Type: Short Survey

References (37)

1. Gallagher HS, Martin JE. An orientation to the concept of minimal breast cancer. Cancer 1971;28:1505-7.
2. Fisher ER, Constantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, et al. Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17: five year observations concerning lobular carcinoma in situ. Cancer 1996;78:1403-16.
3. Swain S. Lobular carcinoma in situ. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, 1997:595-610.
4. Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, 1997.
5. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Breast. In: Handbook for staging of cancer. Philadelphia: JB Lippincott, 1993:161-7.
6. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer 1995;75:1619-26.
7. Tabar L, Fagerberg G, Hsiu-Hsi C, Duffy SW, Smart C, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995;75:2507-17.
8. National Institutes of Health consensus development statement. Breast cancer screening for women ages 40-49. 1997 Jan 21-23. URL: http://odp.od.nih.gov/consensus/statements/cdc/103/103/_stmt.htm.
9. Gamagami P. New early signs in breast cancer. In: Atlas of mammography. Boston, MA: Blackwell Science, 1996:179, 203.
10. Tabar L, Fagerberg G, Day NE, Duffy SW, Kitchin RM. Breast cancer treatment and natural history: new insights from the results of screening. Lancet 1992;339:412-4.
11. Silverstein MJ, Gamagami P, Masetti R, Legmann MD, Craig PH, Gierson ED. Results from a multidisciplinary breast center: analysis of disease discovered. Surg Oncol Clin North Am 1997;6(2):301-14.
12. Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J. Clin Oruol 1989;7:353-56.
13. Rosen HP, Groshen S, Kinne DW, Norton L. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 1993;11: 2090-100.
14. Kopans DB, Halperin E, Hulka CA. Statistical power in breast cancer screening trials and mortality reductions among women 40-49 with particular emphasis on the national breast screening study of Canada. Cancer 1994;74:1196-203.
15. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiation therapy in patients with small cancers of the breast. N Engl J Med 1981;305:6-11.
16. Fisher B, Anderson S, Redmond C, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-61.
17. Fisher B, Anderson S, Fisher E, Redmond C, Wickerham L, Wolmark N, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991;338:327-31.
18. Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 1980;40:2281-7.
19. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328:1587-91.
20. Schnitt SJ, Hayman J, Gelman R, Eberlein T, Love SM, Mayzel K, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 1996;77:1094-100.
21. Fisher B, Redmond C, Fisher E, Bauer M, Wolmark N, Wickerham L, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-81.
22. Hellman S. Natural history of small breast cancers. J Clin Oncol 1994;12:2229-34.
23. Gardner B, Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg 1993;218:270-8.
24. Harris J, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17-21.
25. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994;73:664-7.
26. Silverstein MJ, Waisman JR, Camagami P, Gierson ED, Gamagami P. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of tumor size and palpability. J Am Coll Surg 1995;180:700-4.
27. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997;79:1918-22.
28. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 1994;73:505-8.
29. Giuliano AE, Dale FS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectotny. Ann Surg 1995;222:394-401.
30. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabelled primary lymph nodes. Surg Oncol Clin North Am 1996;5:33-41.
31. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
32. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220: 391-8.
33. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
34. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 1996; 148:649-56.
35. Bostick P, Sarantou T, Huynh K, Conrad A, Chawla S, Giuliano A, et al. A multiple marker RT-PCR assay for detection of occult metastasis in frozen section of sentinel nodes from breast cancer patients [abstract]. Proc Am Soc Clin Oncol 1997;16:153a.
36. Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, et al. Micrometastatic breast cancer cell in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996;88:1652-64.
37. Singletary SE. Skin-sparing mastectomy with immediate breast reconstruction: is it safe? Breast Dis Yearbook Q 1995;6(3)259-60.